Glazer Capital LLC’s Kite Pharma, Inc. KITE Stock Holding History

Glazer Capital LLC’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-198	Closed	-$1K	–	122
2017 Q3	$1K	Buy	+198	New	+$27.6K	﹤0.01%	85

Glazer Capital LLC's KITE Position: Q4 2017 in Review

Glazer Capital LLC sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 293,300 shares — an estimated $52.7M sold.

Glazer Capital LLC first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $52.7M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Glazer Capital LLC reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Glazer Capital LLC sold 293,300 Kite Pharma, Inc. shares in Q4 2017, an estimated $52.7M.
Glazer Capital LLC first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
Glazer Capital LLC's Kite Pharma, Inc. position peaked at $52.7M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Glazer Capital LLC's 13F filing for Q4 2017, filed 14 Feb 2018.